Company intelligence / Profile preview

Gordian Surgical

Delray Beach, Florida, United Statesgordiansurgical.com ↗

Ownership: Private
Development stage: Commercial

Overview

The TroClose™ system has demonstrated a 0% port site hernia rate in clinical use, with significant reductions in tissue tension compared to manual suturing. It improves workflow efficiency and patient outcomes by automating and optimizing laparoscopic port access and closure. The device has FDA clearance and growing international sales

Therapeutic areas: OtherGastroenterology
Modalities: Device (specifically, integrated trocar and wound closure device)
Industry: Surgical Medical Devices

Partnerships

Supported by The Trendlines Group and the Israeli Innovation Authority

Beyond the preview

Go deeper on Gordian Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gordian Surgical.

Explore the full profile